Ranbaxy Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions (NCT01665222) | Ranbaxy Inc. | 2006-10-01 |
| Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions (NCT01665209) | Ranbaxy Inc. | 2006-10-01 |
Track Ranbaxy Inc. automatically
Every clearance here is in the API, with alerts when new ones post.